Immunovant

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.

About IMVT

Immunovant, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on enabling normal lives for patients with autoimmune diseases. 

CEO
Peter Salzmann
CEOPeter Salzmann
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2018
Founded2018
Employees
Employees

IMVT Key Statistics

Market cap
627.19M
Market cap627.19M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$5.54
High today$5.54
Low today
$5.35
Low today$5.35
Open price
$5.38
Open price$5.38
Volume
15.22K
Volume15.22K
52 Week high
$9.54
52 Week high$9.54
52 Week low
$3.15
52 Week low$3.15

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
40%
Sell
10%

IMVT Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.